Lords Mark’s Renalyx gets certification to Manufacture World’s First AI-Based Smart HemoDialysis Machines

This achievement becomes even more historic as LMIL–Renalyx has now received the globally recognised CE marking, making it ...

Lords Mark Industries–Renalyx Wins Licence to Make Class C AI-Based Hemodialysis Machines, Becomes 6th CE-Cert. Brand

Lords Mark Industries–Renalyx earns India’s Class C licence and CE certification to build the world’s first AI-based smart hemodialysis machines, advancing med-tech innovation.

Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease

Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released the following note authored by ...

Lords Mark Industries Ltd.–Renalyx Wins Licence to Manufacture Class C World’s First AI-Based Smart HemoDialysis Machines, Becomes World’s 6th CE-Certified Brand

Securing a licence to manufacture Class C World’s First AI-Based Smart Hemodialysis Machines is one of the toughest ...

As NephroPlus expands abroad, scale turns into its toughest test yet

India’s largest dialysis chain is leaning on higher-priced global markets to lift margins. But rising complexity, staffing ...

Lords Mark Renalyx Wins Licence to Make Class C World's First AI-Based Smart HemoDialysis Machines, Becomes World's 6th CE-Certified Brand

Lords Mark Industries Ltd. (LMIL) has achieved a defining milestone in India's med-tech landscape by receiving the licence to ...

Nephrocare Health IPO: Top 10 key risks investors must know before subscribing to the issue; check latest GMP here

Nephrocare Health IPO opens on December 10, 2025, aiming to raise ₹871.05 crore with a price band of ₹438 to ₹460 per share.